Differential Diagnosis of Mycosis Fungoides: A Review of Literature
PDF
Cite
Share
Request
Review
VOLUME: 19 ISSUE: 1
P: 19 - 26
March 2025

Differential Diagnosis of Mycosis Fungoides: A Review of Literature

Turk J Dermatol 2025;19(1):19-26
1. Department of Dermatology and Venereology, University of Health Sciences Türkiye, Adana Health Practice and Research Center, Adana, Türkiye
2. Department of Dermatology and Venereology, Başkent University Faculty of Medicine, Adana Dr. Turgut Noyan Application and Research Center, Adana, Türkiye
No information available.
No information available
Received Date: 02.10.2024
Accepted Date: 27.10.2024
Online Date: 18.03.2025
Publish Date: 18.03.2025
PDF
Cite
Share
Request

Abstract

Mycosis fungoides (MF), the most common type of cutaneous T-cell lymphoma, often experiences delayed diagnosis because of its ability to mimic numerous other conditions. Early-stage MF patches and plaques are frequently misdiagnosed as eczema, fungal infections, or psoriasis, leading to unnecessary treatments. However, the real challenge in differential diagnosis arises with MF’s clinical variants and atypical localizations. The poikilodermatous variant may be confused with dermatomyositis and lupus erythematosus due to acquired poikiloderma; however, unlike these conditions, MF lesions typically occur in non-sun-exposed areas. MF presenting as pustules clinically resembles pustular psoriasis, subcorneal pustular dermatosis, and folliculitis. Atypical lymphocytes can induce follicular hyperkeratosis, which may lead to MF being mistaken for lichen spinulosus or keratosis pilaris. The bullous variant of MF can present with subcorneal, intraepidermal, or subepidermal vesicle bulla formation, resulting in lesions that resemble erythema multiforme, dyshidrotic eczema, or autoimmune bullous diseases. Both hyperpigmentation and hypopigmentation can be caused by MF. Hypopigmentation can mimic vitiligo, progressive macular hypomelanosis, and leprosy, whereas hyperpigmentation may resemble postinflammatory hyperpigmentation, lichen planus pigmentosus, pigmented actinic keratosis, and ashy dermatosis. Similar to systemic lymphomas, MF can also induce acquired ichthyosis, necessitating differentiation from both systemic and dermatological conditions that cause this skin disorder. In certain systemic lymphomas, such as MF, annular erythematous patches or plaques may develop. Histopathological examination is essential for distinguishing annular lesions that may clinically resemble erythema annular centrifugum, subacute lupus erythematosus, or juvenile annular lichenoid dermatitis. However, the clinical and histopathological findings of MF can vary significantly. When granulomatous infiltration is observed in the dermis, MF can be misdiagnosed as granuloma annular, sarcoidosis, leprosy, or acquired cutis laxa. Solitary erythematous papules, plaques, nodules, or alopecia may occur infrequently, and the differential diagnosis depends on the lesion’s location. The urticarial variant, which is characterized by urticarial lesions, can be mistaken for urticarial drug reactions, T-cell leukemia, and lymphomas. When localized to the palmoplantar region, the condition can be confused with eczema, palmoplantar psoriasis, or palmoplantar keratoderma.

Keywords:
Mycosis fungoides, poikiloderma, folliculitis, hypopigmentation, hyperpigmentation, blister, palmoplantar keratoderma, Woringer-Kolopp disease, granulomatous disease, granulomatous slack skin

INTRODUCTION

Mycosis fungoides (MF) is the most common type of cutaneous T-cell lymphoma. The disease was first described by Jean-Louis Alibert, who observed that the lesions grow like mushrooms and eventually open like decaying fruit, emitting a foul odor.1 Ernest Bazin later described the patch, plaque, and tumor stages of the disease, thereby naming this classical form of MF “Alibert-Bazin disease”.2 Besides the classical Alibert-Bazin type lesions observed in four stages-patch, plaque, tumor, and erythroderma-MF can present with various atypical skin manifestations. In 1938, Sézary and Yves Bouvrain identified large round or polygonal cells with large nuclei in both the skin and blood samples of an erythrodermic patient, leading to the characterization of the erythrodermic subtype.3

Because of its numerous variants, MF is considered a major mimicking disease, such as syphilis. Early-stage patch and plaque lesions of MF are clinically indistinguishable from inflammatory conditions like eczema and psoriasis. To differentiate these conditions, pathological and immunohistochemical examinations are required. However, in patients with MF in whom a diagnosis cannot be made, molecular biological methods such as polymerase chain reaction or Southern blot analysis are used to detect the monoclonality of the T-cell receptor gene.4

Dermoscopic examination is also very useful for differentiating MF from eczema and psoriasis lesions (Figure 1). In eczema, dermoscopy typically reveals vesicles, scale-crusts, and collar-like scales formed after vesicle rupture, while regular globular vascular structures are observed in psoriasis lesions.5 For MF diagnosis, fine linear vessel structures and spermatozoa-like vessels are the most sensitive (93.7%) and specific (97.1%) findings.6 Depending on the clinical type of MF, linear curved vessels, clustered punctate vessels, branching peripheral linear vessels, and red globular structures separated by white lines can also be detected by dermoscopy.7

Another important diagnostic method for distinguishing early-stage MF from psoriasis and eczema is high-frequency ultrasonography. Niu et al.8 evaluated MF and clinically similar inflammatory diseases (psoriasis or eczema) using high-frequency ultrasonography and reported that epidermal thinning was highly sensitive (88%) and specific (75%) for distinguishing MF from psoriasis and eczema.

Early MF lesions can mimic dermatophytic infections (Figure 2). Dermoscopic examination revealed white-peeling scales, broken hairs, and follicular pustules as important clues for dermatophytic infections. Invasive dermatophytic infections, which are often observed in immunosuppressed patients, can also mimic tumoral MF lesions. These infections can be easily differentiated using direct microscopic examination, fungal culture, and various molecular diagnostic methods.9

Differential Diagnosis of Mycosis Fungoides Variants

Poikilodermatous mycosis fungoides: This variant is characterized by more pronounced epidermal atrophy, telangiectasia, and widespread or isolated hypo- and hyperpigmentation (Figure 3). Poikiloderma is not a clinical manifestation specific to a single disease. Connective tissue diseases such as lupus erythematosus and dermatomyositis, Civatte Poikiloderma, excessive use of topical glucocorticoids, radiation dermatitis, graft-versus-host disease, and certain genodermatosis such as Rothmund-Thomson syndrome can cause poikiloderma. In MF, poikilodermatous lesions are localized to flexural areas and sun-protected regions of the trunk, whereas in connective tissue diseases, they appear in sun-exposed areas. For a definitive diagnosis, histopathological examination should reveal epidermal atrophy, pigment loss with mild to moderate vacuolar degeneration in the basal layer, increased melanophage in the papillary and upper reticular dermis, epidermotropism, Pautrier microabscesses, vascular ectasia, and proliferation.10 Rarely, granulomatous dermatitis and syringotropic may also be observed in poikilodermatous MF lesions upon histopathological examination.11, 12 In MF patients, vascular ectasia without atrophy and pigmentation changes may also be observed. This clinical form is called telangiectatic MF. These telangiectasias, which may be unilateral or localized, can be confused with unilateral nevoid telangiectasia or the linear form of telangiectasia macularis eruptiva perstans.13, 14 When erythrocyte extravasation and hemosiderin deposition occur in the dermis due to secondary endothelial cell proliferation caused by T-lymphocytes in MF, it leads to purpuric lesions resembling pigmented purpuric dermatosis (PPD).15 Although not specific, dermoscopic examination of pigmented MF lesions reveals short, fine, linear vessels and spermatozoa-like structures, whereas in PPD lesions, dull red and reticular pigmentation with erythematous globules are observed. Differentiating between MF and PPD is challenging both clinically and histologically. In 1994, Ackerman compared the histopathological features of PPD and MF and noted many similarities between the two.16 FOXP3 positivity has been reported in PMF cases. A positive and statistically significant correlation was found between FOXP3 expression in the dermis and the response to the treatment score. Higher FOXP3 levels in the dermis predict a more severe disease course and poorer response to treatment, including longer time to remission, higher chance of relapse, and shorter remission. A negative and non-significant correlation was found between FOXP3 expression in the epidermis and stage severity.17

Pustular and follicular mycosis fungoides: Pustular MF refers to an extremely rare clinicopathologic variant of MF, initially described by Ackerman et al.18as a chronic vesiculopustular eruption that gradually transforms into typical MF plaques. The pustules may become widespread or confined to the palmoplantar region.18, 19 Histopathological examination revealed typical MF features, such as band-like infiltrates of atypical lymphocytes, epidermotropism, and Pautrier microabscesses, along with subcorneal pustules containing atypical lymphocytes, neutrophils, and eosinophils. These lesions can be confused with pustular psoriasis and subcorneal pustular dermatosis.20Additionally, the development of eosinophilic folliculitis due to hematologic malignancies has been reported. In one case reported in the literature, intense perifollicular infiltration rich in lymphocytes and eosinophils was observed in an MF patient.21 It should also be noted that the presence of pustular lesions is associated with an increased risk of transformation and systemic involvement.22 Staphylococcus aureus (S. aureus) superantigen are known to stimulate T-cells. S. aureus colonization is closely associated with clinical deterioration in patients with MF. Therefore, the presence of Staphylococcus should be investigated via culture in the presence of pustules. Recent data support this by showing that antibiotics inhibit malignant T-cells in skin lesions of MF and Sézary syndrome.23, 24The typical clinical features of folliculotropic MF include hardened erythematous plaques combined with acneiform lesions, including follicular papules, small cysts, and comedones located on the head and neck. These papulopustular lesions can be confused with folliculitis, acne, and alopecias (Figures 4, 5).25 In folliculotropic MF, follicular plugs, perifollicular white areas, and hair loss are observed.26 When follicular MF leads to spiny projections on the skin, it can be mistaken for keratosis pilaris and lichen spinulosus.27 Another common finding of follicular MF is follicular mucinosis, which is characterized by mucinous degeneration of the follicular epithelium, which is more apparent with Alcian blue or other mesenchymal mucin stains.25 The intensely pruritic lesions of folliculotropic MF indicate poor prognosis, similar to tumoral MF.28

Vesiculobullous mycosis fungoides: In the classic form of MF, vesiculation is not observed clinically or histopathologically. However, in rare cases, subcorneal, intraepidermal, or subepidermal vesicle bulla formation may occur in patients with MF. This type, which is characterized by bullous-vesicular lesions, has a poor prognosis, with a 1-year survival rate of approximately 50% following the onset of bullous lesions.29These lesions typically appear as tense or flaccid bullae located on the trunk and extremities (Figure 6). Flaccid bullae may occasionally exhibit Nikolsky positivity.30 While diagnosis is straightforward when bullae accompany classic MF lesions, diagnosis becomes challenging in the presence of isolated bullae. The average time to diagnosis for these patients is 6-7 years. One case report described a delay in diagnosis of up to 40 years due to the disease mimicking autoimmune bullous diseases, erythema multiforme, and dyshidrotic eczema.31, 32 The term “dyshidrotic MF” has been used to describe bullae limited to the palms and soles.33 It should also be remembered that not only MF but also adult T-cell leukemia/lymphomas can present with findings similar to those of dyshidrotic eczema.34 Bullous lesions are rarely associated with Sézary syndrome. This bullae may be due to MF itself or secondary to phototherapy used in the treatment of the disease. When bullous lesions develop, especially in elderly patients with MF, immunofluorescence studies should be conducted to rule out concomitant autoimmune bullous diseases, such as bullous pemphigoid.35 Patients with MF are at risk of herpes simplex virus infection because of decreased cellular immunity and weakened skin barrier. Bullous MF lesions may also occur due to these infections. The tzanck smear test, which is the fastest and most practical test, can be used to differentiate vesiculobullous lesions.36

Hypo/hyperpigmented mycosis fungoides: Although atypical forms of MF generally have a poor prognosis, hyperpigmented MF, which has predominantly been reported in individuals with darker skin tones, is rarely progressive.37More than half of this type of MF, which can be confused with postinflammatory hyperpigmentation, pigmented actinic keratosis, lichen planus pigmentosus, and ashy dermatosis, is associated with CD8+ cytotoxic T-lymphocytes (Figure 7).38 Hypopigmented MF, which also mostly arises due to CD8+ cytotoxic T-lymphocytes, can be confused with diseases causing hypopigmentation, such as vitiligo, progressive macular hypomelanosis, and leprosy. The onset age of hypopigmented MF is earlier than that of classic MF. The onset age of classic MF is between 55 and 60 years, whereas hypopigmented MF typically occurs during pediatric and early adult periods.39 In hypopigmented MF, patch-stage MF findings are accompanied by pigment loss in the basal layer, which can be observed with MART-1 staining.40, 41

Ichthyosiform mycosis fungoides: Several diseases can cause congenital or acquired ichthyosis of the skin. Although congenital forms arise from different genetic mutations, acquired forms can be secondary to certain systemic diseases, medications, skin conditions, and lymphomas. Ichthyosiform MF is a rare clinical variant of MF, accounting for approximately 3.5% of cases. Diagnosis is straightforward when ichthyosis accompanies classic MF lesions, but in patients presenting with only ichthyosis, its diagnosis may be delayed.42 Moreover, adult T-cell leukemia/lymphomas should also be ruled out in such cases.43

Annular mycosis fungoides: When MF lesions exhibit an annular pattern, they can be confused with diseases that cause figurate erythema, such as erythema annular centrifugum, Jessner’s lymphocytic infiltration, annular psoriasis, subacute lupus erythematosus, or juvenile annular lichenoid dermatitis. In rare instances, they may mimic erythema gyratum repens by forming interlocking erythematous rings (Figure 8).44, 45 Annular lesions can also be observed in other types of lymphomas. In patients with follicular lymphoma, the development of annular lesions may indicate transformation into diffuse large B-cell lymphoma.46

Granulomatous mycosis fungoides: Granulomatous MF is a histopathological variant that should be diagnosed through skin biopsy. Findings include perivascular granulomas along with atypical lymphocytes, histiocytes, and multinucleated giant cells in the dermis. Epidermotropism is observed in approximately 50% of cases, thereby complicating diagnosis in patients without characteristic clinical symptoms.47 Histopathological findings of this form can be confused with granuloma annularis, sarcoidosis, and leprosy. This variant has a poor prognosis and is associated with a high risk of secondary lymphoma.48 Granulomatous slack skin syndrome, which has unique clinical and histopathological features, is distinct from granulomatous MF.49 Clinically, these patients present with sagging skin in the axillary or inguinal regions, and histopathological examination reveals prominent elastophagocytosis, differentiating it from granulomatous MF. Dermoscopy revealed pale-orange areas corresponding to granuloma structures on an erythematous background, alongside fine linear vascular structures.50 Granulomatous slack skin can be confused with hematologic diseases that cause acquired cutis laxa,51 and many patients develop secondary lymphoma in the advanced stages.49

Urticarial mycosis fungoides: This extremely rare form of MF is characterized by typical urticarial lesions accompanied by severe pruritus and peripheral blood involvement. It has a favorable prognosis and responds rapidly to treatment. In addition to classic MF findings, histopathology revealed CD25 and FOXP3 positivity on immunophenotyping. Differential diagnoses include urticarial lymphomatoid drug reactions, T-cell prolymphocytic leukemia, Sézary syndrome, and other lymphomas, such as adult T-cell lymphocytic leukemia. This factor should be considered in the differential diagnosis of treatment-resistant urticarial lesions.52

Verrucous mycosis fungoides: Verrucous MF, the least common of its morphological variants, may appear similar to warts, deep fungal infections, seborrheic keratoses or other conditions rather than a neoplastic entity with potentially serious consequences for the patient. The overall incidence of verrucous MF is unknown, and reported cases to date are rare. Verrucous MF lesions are usually asymptomatic and rarely pruritic.53, 54

Solitary or localized mycosis fungoides: This is one of the forms of MF with a good prognosis. It is characterized by isolated macules, plaques, or nodules that have histopathological features that are indistinguishable from those of classic MF. This extremely rare form can also present as an alopecic patch. Depending on the location of the lesions may mimic different diseases (Figure 8). An erythematous plaque localized around the eye may be mistaken for an erysipelas, whereas a nodule in the umbilical region may be confused with a Sister Mary Joseph nodule.55 Because nodules in the umbilical region can also occur in systemic lymphomas other than MF, immunohistochemical staining should be performed.56, 57 In the 2005 WHO/EORTC lymphoma classification, Woringer-Kolopp disease was classified as a solitary variant of MF. Consequently, most solitary MF cases in the literature have been evaluated as Woringer-Kolopp disease (also known as localized pagetoid reticulosis), which is characterized by slow growth, slow clinical progression, and favorable prognosis. Clinically, it usually presents as a solitary lesion in the acral regions of the extremities. The lesion typically presents as a psoriasiform, hyperkeratotic, erythematous plaque.55

Characteristic histopathological findings of pagetoid reticulosis include prominent epidermotropism with an infiltrate of atypical pagetoid lymphocytes, characterized by large and hyperchromatic nuclei surrounded by a pale halo, and epidermal hyperplasia with parakeratosis. Pagetoid reticulosis is typically characterized by a CD8+ immunophenotype, often accompanied by CD30 expression.58 In contrast, solitary MF may show classical histopathological features along with folliculotropic or syringotropism.53 Solitary MF can also be confused with CD4+ small/medium-sized pleomorphic T-cell lymphoma and CD8+ lymphoproliferative disorder of the ear/face, both clinically and histopathologically. Although dermal atypical lymphocytes are not observed in Woringer-Kolopp disease, CD8+ lymphoproliferative disorder of the ear/face is characterized by a dense dermal infiltration of monomorphic medium-sized atypical lymphocytes, with less than 5% large cells.59

Although MF typically localizes to non-sun-exposed areas, in some patients, it may localize to acral regions, mimicking eczema, palmoplantar psoriasis, and palmoplantar keratoderma. If not considered in the differential diagnosis, patients may use topical keratolytic drugs or steroid creams for years.60 Syringotropic MF is a rare clinicopathologic variant of MF characterized by eccrine gland involvement. Clinical findings include erythematous papules and plaques that may or may not be associated with follicular eruptions. Adnexal involvement frequently leads to anhidrosis and alopecia.61 The condition can be confused with punctate keratoderma when palmoplantar involvement is present.62 When localized to sun-exposed areas, it may mimic chronic actinic dermatitis, and when located at the corner of the lips, it may be mistaken for angular cheilitis.62, 63 Mucosal involvement is rare in MF and is a poor prognostic indicator. The majority of patients die within 3 years of the discovery of mucosal involvement. Oral mucosal involvement was observed in 18.6% of patients with MF who underwent autopsy. Patients with MF should be carefully evaluated for oral, genital, and nasal mucosal symptoms. Mucosal involvement mimics many benign inflammatory conditions and malignant diseases both clinically and microscopically.64, 65 Rarely, when it develops without cutaneous manifestations, it may present as a geographic tongue-like appearance.66

CONCLUSION

MF mimics many dermatological diseases because of its wide range of clinical manifestations. For early diagnosis, the disease should be considered, and close collaboration with pathologists is essential.

Authorship Contributions

Surgical and Medical Practices: T.T., M.D., Concept: T.T., M.D., Design: T.T., M.D., Data Collection or Processing: T.T., M.D., Analysis or Interpretation: T.T., M.D., Literature Search: T.T., M.D., Writing: T.T., M.D.
Conflict of Interest: The authors declared that they have no conflict of interest.
Financial Disclosure: The authors declared that this study received no financial support.

References

1
Long V. The life and art of Alibert’s dermatology. Clin Dermatol. 2022;40:293-296.
2
Kazakov DV, Burg G, Kempf W. Clinicopathological spectrum of mycosis fungoides. J Eur Acad Dermatol Venereol. 2004;18:397-415.
3
Steffen C. The man behind the eponym dermatology in historical perspective: Albert Sézary and the Sézary syndrome. Am J Dermatopathol. 2006;28:357-367.
4
Curcó N, Servitje O, Llucià M, Bertran J, Limón A, Carmona M, Romagosa V, Peyrí J. Genotypic analysis of cutaneous T-cell lymphoma: a comparative study of Southern blot analysis with polymerase chain reaction amplification of the T-cell receptor-gamma gene. Br J Dermatol. 1997;137:673-679.
5
Bilgic SA, Cicek D, Demir B. Dermoscopy in differential diagnosis of inflammatory dermatoses and mycosis fungoides. Int J Dermatol. 2020;59:843-850.
6
Lallas A, Apalla Z, Lefaki I, Tzellos T, Karatolias A, Sotiriou E, Lazaridou E, Ioannides D, Zalaudek I, Argenziano G. Dermoscopy of early stage mycosis fungoides. J Eur Acad Dermatol Venereol. 2013;27:617-621.
7
Errichetti E, Apalla Z, Geller S, Sławińska M, Kyrgidis A, Kaminska-Winciorek G, Jurakic Toncic R, Bobos M, Rados J, Ledic Drvar D, Ceovic R, Akay BN, Piccolo V, Myskowski P, Vitiello P, Russo T, Argenziano G, Sokołowska-Wojdyło M, Sobjanek M, Stojkovic-Filipovic J, Longo C, Pellacani G, Stinco G, Lallas A. Dermoscopic spectrum of mycosis fungoides: a retrospective observational study by the International Dermoscopy Society. J Eur Acad Dermatol Venereol. 2022;36:1045-1053.
8
Niu Z, Wang Y, Zhu Q, Liu J, Liu Y, Jin H. The value of high-frequency ultrasonography in the differential diagnosis of early mycosis fungoides and inflammatory skin diseases: a case-control study. Skin Res Technol. 2021;27:453-460.
9
Tan J, Yu Q, Gao Z, Yang H, Chen Q, Yang L. Case report: severe deep ulcer on the left abdomen mimicking mycosis fungoides caused by Trichophyton tonsurans in a patient with novel CARD9 mutation. Front Immunol. 2022;13:1015000.
10
Apalla Z, Lallas A, Katodritou E, Fotiadou C, Lazaridou E, Bobos M. Dermoscopy of poikilodermatous mycosis fungoides: a case escaping diagnosis for three decades. Photodermatol Photoimmunol Photomed. 2021;37:250-252.
11
Morihara K, Katoh N, Takenaka H, Kihara K, Morihara T, Kishimoto S. Granulomatous mycosis fungoides presenting as poikiloderma. Clin Exp Dermatol. 2009;34:718-720.
12
Lehmer LM, Amber KT, de Feraudy SM. Syringotropic mycosis fungoides: a rare form of cutaneous T-cell lymphoma enabling a histopathologic “sigh of relief”. Am J Dermatopathol. 2017;39:920-923.
13
García-Colmenero L, Curto-Barredo L, Gómez-Martin I, Gallardo F, Pujol RM. Telangiectatic mycosis fungoides: a new clinicopathological presentation mimicking acquired naevoid telangiectasia. Acta Derm Venereol. 2017;97:651-652.
14
Kagimoto Y, Mizuashi M, Iizawa O, Aiba S. Linear telangiectasia macularis eruptiva perstans mimicking acquired nevoid telangiectasia in a 5-year-old girl. Int J Dermatol. 2012;51:69-71.
15
Gökyayla E, Çetinarslan T, Temiz P, Türel Ermertcan A. Mycosis fungoides mimicking pigmented purpuric dermatosis. Dermatol Ther. 2020;33:e14062.
16
Toro JR, Sander CA, LeBoit PE. Persistent pigmented purpuric dermatitis and mycosis fungoides: simulant, precursor, or both? A study by light microscopy and molecular methods. Am J Dermatopathol. 1997;19:108-118.
17
Perelman M, Rozenblat M, Ellenbogen E, Geller S, Slutsky Bank E, Eytan O, Gat A, Sprecher E, Goldberg I. FOXP3 predicts response to treatment in mycosis fungoides. Acta Dermatovenerol Croat. 2021;29:67-71.
18
Ackerman AB, Miller RC, Shapiro L. Pustular mycosis fungoides. Arch Dermatol. 1966;93:221-225.
19
Tagami H, Aiba S, Ohkouchi K. Palmoplantar pustular lesions in mycosis fungoides. J Am Acad Dermatol. 1991;25:733-734.
20
Pabsch H, Kunze J, Schaller J. Mycosis fungoides presenting as a pustular eruption. J Am Acad Dermatol. 2009;61:908-909.
21
Takashima S, Nishie W, Morita Y, Osawa R, Iwata H, Fujita Y, Fujimoto K, Shimizu H. Eosinophilic pustular folliculitis in a patient with mycosis fungoides. J Eur Acad Dermatol Venereol. 2016;30:712-713.
22
Badrignans M, Oro S, Chong-Si-Tsaon A, Bagny K, Le Masson G, Legoupil D, Attencourt C, Dubois R, Faiz S, Beltzung F, D’Incan M, Koubaa W, Skrek S, Beltraminelli H, Balme B, Dalle S, Moustaghfir I, Chaby G, Deschamps T, Ortonne N. Pustular mycosis fungoides has a poor outcome: a clinico-pathological and longitudinal study of 36 cases. Eur J Cancer. 2021;156 Suppl 1:S23-S24.
23
Talpur R, Bassett R, Duvic M. Prevalence and treatment of Staphylococcus aureus colonization in patients with mycosis fungoides and Sézary syndrome. Br J Dermatol. 2008;159:105-112.
24
Jackow CM, Cather JC, Hearne V, Asano AT, Musser JM, Duvic M. Association of erythrodermic cutaneous T-cell lymphoma, superantigen-positive Staphylococcus aureus, and oligoclonal T-cell receptor V beta gene expansion. Blood. 1997;89:32-40.
25
Marschalkó M, Erős N, Kontár O, Hidvégi B, Telek J, Hársing J, Jókai H, Bottlik G, Rajnai H, Szepesi Á, Matolcsy A, Kárpáti S, Csomor J. Folliculotropic mycosis fungoides: clinicopathological analysis of 17 patients. J Eur Acad Dermatol Venereol. 2015;29:964-972.
26
Wang L, Xu AE. Early dermoscopic patterns of folliculotropism in patients with mycosis fungoides. Clin Exp Dermatol. 2021;46:1599-1601.
27
Tomasini C, Michelerio A, Quaglino P. Spiky/keratosis-pilaris-like early follicular mycosis fungoides: a clinicopathologic study of 20 cases with extended follow-up. J Cutan Pathol. 2021;48:1124-1132.
28
Muniesa C, Estrach T, Pujol RM, Gallardo F, Garcia-Muret P, Climent J, Servitje O. Folliculotropic mycosis fungoides: clinicopathological features and outcome in a series of 20 cases. J Am Acad Dermatol. 2010;62:418-426.
29
Bowman PH, Hogan DJ, Sanusi ID. Mycosis fungoides bullosa: report of a case and review of the literature. J Am Acad Dermatol. 2001;45:934-939.
30
McBride SR, Dahl MG, Slater DN, Sviland L. Vesicular mycosis fungoides. Br J Dermatol. 1998;138:141-144.
31
Juan-Carpena G, Palazón-Cabanes JC, Blanes-Martínez M. Successful treatment of palmoplantar dyshidrotic lesions of mycosis fungoides with conventional and daylight photodynamic therapy. J Dtsch Dermatol Ges. 2021;19:1045-1047.
32
Bernardini ML, Brandozzi G, Campanati A, Giangiacomi M, Offidani A. Bullous-vesicular variant of mycosis fungoides presenting as erythema annulare centrifugum: a case report. J Eur Acad Dermatol Venereol. 2009;23:839-840.
33
Diehl J, Sarantopoulos GP, Chiu MW. Dyshidrotic mycosis fungoides. J Cutan Pathol. 2011;38:590-592.
34
Bittencourt AL, Mota K, Oliveira RF, Farré L. A dyshidrosis-like variant of adult T-cell leukemia/lymphoma with clinicopathological aspects of mycosis fungoides. A case report. Am J Dermatopathol. 2009;31:834-837.
35
Küçükoğlu R, Pehlivan G, Büyükbabani N. Mycosis fungoides occurrence in a patient with bullous pemphigoid. Dermatol Ther. 2020;33:e14015.
36
Gottesman SP, Rosen JR, Geller JD, Freeman BB. Atypical Varicella-Zoster Kaposi Varicelliform Eruption in Sézary Syndrome. Am J Dermatopathol. 2018;40:920-923.
37
Jung JM, Lee MY, Won CH, Chang SE, Lee MW, Lee WJ. Hyperpigmented mycosis fungoides: a retrospective and comparative analysis with other subtypes of mycosis fungoides. Leuk Lymphoma. 2022;63:1598-1606.
38
Kalay Yildizhan I, Sanli H, Akay BN, Sürgün E, Heper A. CD8+ cytotoxic mycosis fungoides: a retrospective analysis of clinical features and follow-up results of 29 patients. Int J Dermatol. 2020;59:127-133.
39
Stone ML, Styles AR, Cockerell CJ, Pandya AG. Hypopigmented mycosis fungoides: a report of 7 cases and review of the literature. Cutis. 2001;67:133-138.
40
Djawad K. Hypopigmented mycosis fungoides mimicking leprosy successfully treated with oral and topical corticosteroids: a new great imitator?. Acta Dermatovenerol Alp Pannonica Adriat. 2021;30:83-85.
41
Kim JC, Kim YC. Hypopigmented mycosis fungoides mimicking vitiligo. Am J Dermatopathol. 2021;43:213-216.
42
Hodak E, Amitay I, Feinmesser M, Aviram A, David M. Ichthyosiform mycosis fungoides: an atypical variant of cutaneous T-cell lymphoma. J Am Acad Dermatol. 2004;50:368-374.
43
Nguyen GH, Wang JY, Hymes KB, Magro CM. An Index case of concomitant tumoral and ichthyosiform mycosis fungoides-like presentation of chronic adult T-cell leukemia/lymphoma associated with upregulation of TOX. Am J Dermatopathol. 2017;39:28-32.
44
Lim DS, Murphy GM, Egan CA. Mycosis fungoides presenting as annular erythema. Br J Dermatol. 2003;148:591.
45
Notay M, Petukhova TA, Kiuru M, Kunder CA, Hwang ST. Mycosis fungoides presenting as symmetric concentric patches mimicking figurate erythema. JAAD Case Rep. 2017;3:288-290.
46
Palacios-Álvarez I, Román-Curto C, García-Sancho AM, Santos-Briz Á, Santos-Durán JC, Fernández-López E. Cutaneous annular lesions as the first sign of transformation of follicular lymphoma into diffuse large B-cell lymphoma. Indian J Dermatol Venereol Leprol. 2015;81:495-497.
47
Ahn CS, ALSayyah A, Sangüeza OP. Mycosis fungoides: an updated review of clinicopathologic variants. Am J Dermatopathol. 2014;36:933-951.
48
Li JY, Pulitzer MP, Myskowski PL, Dusza SW, Horwitz S, Moskowitz A, Querfeld C. A case-control study of clinicopathologic features, prognosis, and therapeutic responses in patients with granulomatous mycosis fungoides. J Am Acad Dermatol. 2013;69:366-374.
49
Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, Ralfkiaer E, Chimenti S, Diaz-Perez JL, Duncan LM, Grange F, Harris NL, Kempf W, Kerl H, Kurrer M, Knobler R, Pimpinelli N, Sander C, Santucci M, Sterry W, Vermeer MH, Wechsler J, Whittaker S, Meijer CJ. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768-3785.
50
Balais G, Lallas A, Lazaridou E, Kanatli L, Apalla Z. Granulomatous Slack Skin: a case report. Dermatol Pract Concept. 2020;10:e2020044.
51
Echeverria B, Vitiello M, Milikowski C, Kerdel F. Granulomatous slack skin-like clinical findings in Sézary syndrome. J Cutan Pathol. 2015;42:992-995.
52
Torre-Castro J, Postigo C, Machan S, Jo-Velasco ME, Díaz de la Pinta J, Rodríguez-Peralto JL, Córdoba R, Requena L, Rodríguez-Pinilla SM. Urticarial mycosis fungoides: a distinctive presentation with blood involvement and a peculiar immunophenotype. J Cutan Pathol. 2024;51:649-653.
53
Bunata K, Jahan-Tigh RR, Curry J, Duvic M. A verrucous presentation of mycosis fungoides. Dermatol Online J. 2014;20:13030.
54
Schlichte MJ, Talpur R, Venkatarajan S, Curry JL, Nagarajan P, Duvic M. Verrucous presentation in patients with mycosis fungoides. Int J Dermatol. 2016;55:e126-e129.
55
Ally MS, Pawade J, Tanaka M, Morris S, Mitchell T, Child F, Wain M, Whittaker S, Robson A. Solitary mycosis fungoides: a distinct clinicopathologic entity with a good prognosis: a series of 15 cases and literature review. J Am Acad Dermatol. 2012;67:736-744.
56
Weyers W, Diaz-Cascajo C, Preinfalk P, Löffler H. Mycosis fungoides mimicking erysipelas. J Dtsch Dermatol Ges. 2008;6:298-301.
57
Belcadi J, Oulad Ali S, Elouarith I, Znati K, Ismaili N, Benzekri L, Senouci K, Meziane M. Mycosis fungoides mimicking a nodule of Sister Mary Joseph. JAAD Case Rep. 2022;25:9-12.
58
Jacyk WK, Grayson W, Dinkel JE, Requena L. Pagetoid reticulosis with CD30 positivity and cytotoxic/suppressor cells. J Cutan Pathol. 2007;34:644-647.
59
Grogg KL, Jung S, Erickson LA, McClure RF, Dogan A. Primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma: a clonal T-cell lymphoproliferative disorder with indolent behavior. Mod Pathol. 2008;21:708-715.
60
Kim J, Foster R, Lam M, Kumarasinghe SP. Mycosis fungoides: an important differential diagnosis for acquired palmoplantar keratoderma. Australas J Dermatol. 2015;56:49-51.
61
Pileri A, Facchetti F, Rütten A, Zumiani G, Boi S, Fink-Puches R, Cerroni L. Syringotropic mycosis fungoides: a rare variant of the disease with peculiar clinicopathologic features. Am J Surg Pathol. 2011;35:100-109.
62
Lebas E, Collins P, Somja J, Nikkels AF. A comprehensive update of the atypical, rare and mimicking presentations of mycosis fungoides. Dermatol Ther (Heidelb). 2021;11:1931-1951.
63
Sinha A, Pathania V, Sood A, Shelly D. Mycosis fungoides with photosensitivity mimicking chronic actinic dermatitis. Indian Dermatol Online J. 2020;12:337-339.
64
Vicente A, Martí RM, Martín E, Estrach T, Herrero C, Mascaró JM. Mycosis fungoides with oral involvement. Int J Dermatol. 1991;30:864-866.
65
Gruson LM, Heller P, Hemmerdinger SA, Latkowski JA. Mycosis fungoides involving the nasal mucosa. J Am Acad Dermatol. 2007;56:S112-S114.
66
Rosebush MS, Allen CM, Accurso BT, Baiocchi RA, Cordell KG. Oral mycosis fungoides: a report of three cases and review of the literature. Head Neck Pathol. 2019;13:492-499.